Gaudium IVF and Women Health IPO
Gaudium IVF and Women Health Limited
Minimum Investment
About Company
Company Name: Gaudium IVF and Women Health Limited
Industry / Sector: Healthcare / Fertility & IVF Services
Founded Year: 2015
Promoters: Dr. Manika Khanna, Dr. Peeyush Khanna, Vishad Khanna
Incorporated in March 2015, Gaudium IVF and Women Health Limited provides In Vitro Fertilization (IVF) treatments and fertility services across India using a hub-and-spoke model. It operates over 30 locations (7 hubs/centres and 28 spokes) through strategic alliances with Infertility Experts. The company offers specialized fertility treatments including IVF, ICSI, IUI, ovulation induction, and comprehensive gynaecological care for PCOD/PCOS, endometriosis, high-risk pregnancies, and male infertility (advanced sperm retrieval). It serves patients from India and international countries (Canada, UK, US, Kenya, South Africa, Oman). Key centres are in Delhi (Janakpuri, Kailash Colony), Mumbai (Khar West), Ludhiana, Srinagar, Patna, and Bangalore. The company uses next-gen INTEGRA Ti labs for ICSI and highly technical USG-guided services.
IPO Basic Details
| Company Name | Gaudium IVF and Women Health Limited |
| IPO Type | Mainboard IPO |
| Price Band | ₹75 – ₹79 |
| Lot Size | 189 |
| Total Issue Size | ₹165 Cr (20,886,200 shares) |
IPO Strengths & Risks
Strengths
- Patient-centric approach
- Expert team
- Next-gen INTEGRA Ti labs for ICSI
- Highly technical USG-guided services
- Established central hubs in prime urban locations (Mumbai, Bangalore, Delhi NCR, Patna)
- Asset-light business model
Risks
- Not explicitly detailed on page (typical: regulatory changes in healthcare, competition in IVF, success rate dependency, high capex for centres)
IPO Important Dates
| IPO Open Date | 20 Feb 2026 |
| IPO Close Date | 24 Feb 2026 |
| Basis of Allotment | 25 Feb 2026 |
| Refund Initiation | 25 Feb 2026 |
| Demat Credit Date | 26 Feb 2026 |
| Listing Date | 27 Feb 2026 |
| Anchor Investor Date | - |
| UPI Mandate Deadline | - |
IPO Objectives
- Capital expenditure for machinery and equipment – -
- Funding working capital requirements – -
- Debt repayment – -
- General corporate purposes – ₹12.28 Cr
Investor Reservation
| QIB Quota | 50.00% (10,443,100 shares; Anchor 30.00% / 6,265,860 shares; QIB ex-anchor 20.00% / 4,177,240 shares) |
| Retail Quota | 35.00% (7,310,170 shares) |
| HNI Quota | 15.00% (3,132,930 shares; bNII 10.00% / 2,088,620 shares; sNII 5.00% / 1,044,310 shares) |
| Employee Quota | - |
| Shareholder Quota | - |
| Anchor Investor Allocation | - |
Market Lot Details
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 lot | 189 | ₹14,931 |
| Retail Maximum | 13 lots | 2457 | ₹1,94,103 |
| S-HNI Minimum | 14 lots | 2646 | ₹2,09,034 |
| S-HNI Maximum | 66 lots | 12474 | ₹9,85,446 |
| B-HNI Minimum | 67 lots | 12663 | ₹10,00,377 |
Key Performance Indicators (KPI)
| ROE | 21.25% (Sep 30, 2025) / 41.31% (Mar 31, 2025) |
| ROCE | 21.03% (Sep 30, 2025) / 39.70% (Mar 31, 2025) |
| RoNW | 21.34% (Sep 30, 2025) / 41.71% (Mar 31, 2025) |
| PAT Margin | 25.14% (Sep 30, 2025) / 26.96% (Mar 31, 2025) |
| EBITDA Margin | 38.29% (Sep 30, 2025) / 40.48% (Mar 31, 2025) |
| EPS | - |
| NAV per share | - |
| Debt to Equity | 0.38 (Sep 30, 2025) / 0.41 (Mar 31, 2025) |
| P/E Ratio | - |
| Industry P/E | - |
Company Financial Data
| Period | Assets | Total Income | PAT | EBITDA | Net Worth | Borrowings |
|---|---|---|---|---|---|---|
| 31 Mar 2023 | ₹36.63 Cr | ₹44.26 Cr | ₹13.53 Cr | ₹20.07 Cr | ₹22.73 Cr | ₹9.78 Cr |
| 31 Mar 2024 | ₹51.01 Cr | ₹48.15 Cr | ₹10.32 Cr | ₹19.27 Cr | ₹26.99 Cr | ₹15.73 Cr |
| 31 Mar 2025 | ₹88.51 Cr | ₹70.96 Cr | ₹19.13 Cr | ₹28.63 Cr | ₹46.30 Cr | ₹18.93 Cr |
| 30 Sep 2025 | ₹106.62 Cr | ₹49.75 Cr | ₹12.51 Cr | ₹18.95 Cr | ₹58.85 Cr | ₹22.51 Cr |
Grey Market Premium
| GMP Price | ₹5 (6.33%) pre-listing (Day 3 reports) |
| Kostak Rate | N/A |
| Subject to Sauda | N/A |
| Last Updated | Feb 2026 |
| Estimated Listing Price | ₹84 (moderate; actual listed at ₹83 on NSE/BSE, +5.06% premium) |
IPO Subscription Data
| Total Subscription | 7.27x (final on Feb 24, 2026 6:54:51 PM) |
| QIB (Ex Anchor) | 1.62x |
| HNI Subscription | 14.05x |
| Retail Subscription | 7.60x |
| Anchor | - |
IPO Intermediaries
Registrar: Bigshare Services Pvt.Ltd.
Registrar Website: https://ipo.bigshareonline.com/IPO_Status.html
IPO Lead Manager(s)
Company Information
Address: B1/51,Janak Puri,B-1,New Delhi, New Delhi, 110058
Website: https://www.gaudiumivfcentre.com/
Email: compliance@gaudiumivfcentre.com
Phone: 011-4885 8585
IPO Documents
Explore More Investment Opportunities
Discover IPOs, unlisted shares, and broker comparison tools curated for smart investors.